We further explored possible alterations in the cancer-immune cycle, and we found that the activity of C3 was significantly up-regulated in the second, third, and fourth steps, but significantly down-regulated in the fifth step (immune cell infiltration into the tumor) (Figure 5I), which may explain the underlying mechanism of better immune infiltration and worse prognosis of the C3 subtype. Here, C3 is linked to cancer.